Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9145
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chu, Wen-Kai | - |
dc.contributor.author | Wu, Un-In | - |
dc.contributor.author | Lee, Tai-Fen | - |
dc.contributor.author | Cheng, Aristine | - |
dc.contributor.author | Chen, Kai-Hsiang | - |
dc.contributor.author | Lin, Kuan-Yin | - |
dc.date.accessioned | 2024-12-17T03:00:27Z | - |
dc.date.available | 2024-12-17T03:00:27Z | - |
dc.date.issued | 2023-02 | - |
dc.identifier.citation | Short Communication | en_US |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/9145 | - |
dc.description.abstract | is. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to liposomal amphotericin B, but progressed under voriconazole and posaconazole maintenance therapy. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Journal of Microbiologi, Immunology and Infection | en_US |
dc.subject | Histoplasma capsulatum | en_US |
dc.subject | Rheumatoid arthritis | en_US |
dc.subject | Salvage treatment | en_US |
dc.subject | Voriconazole | en_US |
dc.subject | Posaconazole | en_US |
dc.subject | Non-endemic area | en_US |
dc.title | A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 56 NO 1 2023 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
192-196.pdf | 548.88 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.